Rappta Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Rappta Therapeutics General Information

Description

Operator of a pharmaceutical company intended to develop a key tumor suppressor and a critical enzyme. The company's scientists have unraveled protein phosphatase two A's complexity and it has proprietary development tools that have facilitated rational drug design, enabling patients to access a therapeutic opportunity across diverse cancer types and in certain important non-oncology indications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Haartmaninkatu 4
  • Terkko Health Hub
  • 00290 Helsinki
  • Finland
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Corporate Office
  • Haartmaninkatu 4
  • Terkko Health Hub
  • 00290 Helsinki
  • Finland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rappta Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 13-Oct-2020 Completed Pre-Clinical Trials
To view Rappta Therapeutics’s complete valuation and funding history, request access »

Rappta Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Rappta Therapeutics’s complete cap table history, request access »

Rappta Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to develop a key tumor suppressor and a critical enzyme. The company's sci
Drug Discovery
Helsinki, Finland
11 As of 2023

Helsinki, Finland
 

Helsinki, Finland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rappta Therapeutics Competitors (4)

One of Rappta Therapeutics’s 4 competitors is Valo Therapeutics, a Venture Capital-Backed company based in Helsinki, Finland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Valo Therapeutics Venture Capital-Backed Helsinki, Finland
TILT Biotherapeutics Venture Capital-Backed Helsinki, Finland
Centrose Venture Capital-Backed Madison, WI
Faron Pharmaceuticals Corporation Turku, Finland
To view Rappta Therapeutics’s complete competitors history, request access »

Rappta Therapeutics Patents

Rappta Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023318912-A1 Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators Pending 04-Aug-2022
EP-4565323-A1 Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators Pending 04-Aug-2022
US-20260265190-A1 Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators Pending 04-Aug-2022
WO-2024028808-A1 Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators Inactive 04-Aug-2022
EP-4288412-A1 Modulators of protein phosphatase 2a (pp2a) and methods using same Pending 08-Feb-2021 C07D211/96
To view Rappta Therapeutics’s complete patent history, request access »

Rappta Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rappta Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advent Life Sciences Venture Capital Minority
Business Finland Government Minority
Novartis Venture Fund Corporate Venture Capital Minority
Novo Holdings Venture Capital Minority
To view Rappta Therapeutics’s complete investors history, request access »

Rappta Therapeutics FAQs

  • When was Rappta Therapeutics founded?

    Rappta Therapeutics was founded in 2019.

  • Where is Rappta Therapeutics headquartered?

    Rappta Therapeutics is headquartered in Helsinki, Finland.

  • What is the size of Rappta Therapeutics?

    Rappta Therapeutics has 11 total employees.

  • What industry is Rappta Therapeutics in?

    Rappta Therapeutics’s primary industry is Drug Discovery.

  • Is Rappta Therapeutics a private or public company?

    Rappta Therapeutics is a Private company.

  • What is Rappta Therapeutics’s current revenue?

    The current revenue for Rappta Therapeutics is .

  • How much funding has Rappta Therapeutics raised over time?

    Rappta Therapeutics has raised $10.6M.

  • Who are Rappta Therapeutics’s investors?

    Advent Life Sciences, Business Finland, Novartis Venture Fund, and Novo Holdings have invested in Rappta Therapeutics.

  • Who are Rappta Therapeutics’s competitors?

    Valo Therapeutics, TILT Biotherapeutics, Centrose, and Faron Pharmaceuticals are competitors of Rappta Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process